ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007
  Rachel Johnson |   Terry Mamounas |   William Gradishar |
Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer?
REFERENCE: Abstract: 2090
RACHEL JOHNSON, Christie Hospital, Manchester
Some patients with HER-2 positive early breast cancer fare better if trastuzumab is withheld, according to